Insights from long-term follow-up of patients treated with oral immunotherapy for cow's milk allergy.

Authors

Lais Ferreira Lopes Brum, Nayara Maria Furquim Nasser, Glauce Hiromi Yonamine, Thais Costa Lima de Moura, Mayra de Barros Dorna, Antonio Carlos Pastorino, Beni Morgenstern, Ana Paula Moschione Castro

Published in

Einstein (Sao Paulo, Brazil). Volume 24. Pages eAO2168. Epub Aug 21, 2026.

Abstract

To describe the long-term outcomes of patients undergoing oral immunotherapy for cow's milk allergy in a pediatric allergy clinic, focusing on treatment efficacy and adverse reactions over 5 years of follow-up.
This retrospective cohort study reviewed medical records of patients aged 5-18 years who underwent cow's milk oral immunotherapy at Instituto da Criança, São Paulo. All patients initiated treatment between 2013 and 2019 and completed at least 5 years of maintenance follow-up. Evaluated outcomes included treatment adherence, adverse reactions, anaphylaxis, and eosinophilic esophagitis. Data were analyzed descriptively, and statistical tests were applied.
Thirty patients entered the maintenance phase (median age, 8.2 years). Most had allergic comorbidities and a history of anaphylaxis. Four patients discontinued treatment within the first trimester: two due to anaphylaxis and two due to eosinophilic esophagitis. Adverse reactions were predominantly mild and decreased significantly over time (p=0.01). Severe reactions accounted for 17% of events, including 22 episodes of anaphylaxis. Eosinophilic esophagitis was diagnosed in 33% of patients and occurred more frequently among those initiating treatment after 12 years of age.
Long-term oral immunotherapy increased tolerance and enabled regular milk ingestion in most patients. Older age at treatment initiation was associated with a higher incidence of eosinophilic esophagitis. Careful patient selection and structured monitoring during and after treatment are essential for early identification of severe reactions and eosinophilic esophagitis. Larger studies with longer follow-up are needed to optimize protocols and improve safety strategies.

PMID:
42659447
Bibliographic data and abstract were imported from PubMed on 28 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.